Scammell- pharmocological Rx of breast cancer Flashcards

(40 cards)

1
Q

does combination birth control pills for premenopausal patients have a link to breast cancer

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

does topical vaginal estrogen products have a link to breast cancer in peri and post-menopausal patients

A

no

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

increases risk of breast cancer BUT reduces risk of endometrial cancer

A

progestin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

____ approved that is an estrogen antagonist at breast and endometrium while getting estrogen benefits elsewhere

A

SERM

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

hormonal therapy taken for ____ years for breast cancer treatment

A

5-10

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

selective estrogen receptor modulator (SERM) used to treat breast cancer in premenopausal women

A

Tamoxifen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

increased risk of endometrial cancer and blood clots with this medicine

A

Tamoxifen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

aromatase inhibitor used to treat breast cancer in postmenopausal women

A

Letrozole, Anastrazole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

won’t see estrogenic effects with _____ inhibitors b/c estradiol levels are low

A

aromatase

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

SE of hormonal therapy

A

menopausal symptoms, risk of endometrial cancer and blood clots

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

___ promotes the growth of cancers that are estrogen receptor +

A

estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

hormone receptor + means ___ and ___ receptor +

A

estrogen and progesterone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

___ increases progesterone receptor synthesis, so ____ receptor + tissues have both ER and PR

A

estrogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

stop estrogen from acting (SERM or SERD) OR
lower estradiol levels (aromatase inhibitor) OR
inhibit estradiol secretion

A

hormone therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

if the cancer is ER- and PR-, ___ therapy is ineffective

A

hormone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Estrogens agonists at some tissues, BUT
estrogens antagonists at others

A

SERM (selective estrogen receptor modulators)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

to treat ER + breast cancer: antagonist at the breast; agonist at the endometrium and clotting factors (endometrial cancer and blood clot risks)

18
Q

SERM that is pro-fertility, antagonist at hypothalamus and increase in GnRH

19
Q

SERD (selective ER depleter or down-regulator); blocks the estrogen receptor and the receptor is degraded intracellularly
Second-line therapy in metastatic breast cancer after initial failure

20
Q

SE of this drug is hot flashes and night sweats due to antagonism of some effects of estrogen

21
Q

letrozole, anastrazole, exemestane

A

aromatase inhibitors

22
Q

used in premenopausal women for fertility induction + postmenopausal women for breast cancer treatment

A

Letrozole, Anastrazole

23
Q

SE of aromatase inhibitors

A

bone thinning, osteoporosis

24
Q

acts at GnRH receptor and downregulates entire pathway; decreases FSH secretion and decreases estradiol

25
feedback at hypothalamus and pituitary to decrease FSH secretion; decrease FSH secretion and decrease estradiol
progestin and androgen
26
is expressed on 20% of breast cancer cells and stimulates growth
HER2
27
monoclonal antibody to HER2 Main side effect is cardiovascular especially if combined with doxorubicin
Trastuzumab (Herceptin)
28
targets HER2 but at a different site than trastuzumab; given together for synergistic effect
Pertuzumab
29
the monoclonal antibodies to treat breast cancer can be used with what other 2 inhibitors
tyrosine kinase inhibitor CDK 4/6 inhibitor
30
do not get chemo
31
topoisomerase II inhibitor used to treat triple - breast cancer
doxorubicin
32
main toxicity of doxorubicin
cardiac
33
stabilizes microtubules; used to treat triple - breast cancer
paclitaxel
34
main SE of paclitaxel
neuropathy
35
inhibits thymidylate synthase; used to treat triple - breast cancer
5--fluorouracil
36
main SE of 5-fluorouracil
neurotoxicity
37
alkylates DNA; used to treat triple - breast cancer
cyclophosphamide
38
main SE of cyclophosphamide
hemorrhagic cystitis
39
Inhibit osteoclastic activity, decrease bone turnover; used in osteoporosis, bone pain and bone metastasis of breast cancer
bisphosphonates
40
Monoclonal Ab that inhibits osteoclast activity by binding to RANK; used in osteoporosis and bone pain for bone metastasis of breast cancer
Denosumab